Antagonistes 2-pyridyloxy-4-éther des récepteurs de l'orexine

2-pyridyloxy-4-ether orexin receptor antagonists

Abstract

The present invention is directed to 2-pyridyloxy-4-ether compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the 2-pyridyloxy-4-ether compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved..
La présente invention concerne des composés 2-pyridyloxy-4-éther antagonistes des récepteurs de l'orexine. La présente invention concerne également des utilisations des dits composés 2-pyrydyloxy-4-éther comme possibilités de traitement ou de prévention de troubles et de maladies neurologiques et psychiatriques dans lesquelles sont impliqués les récepteurs de l'orexine. La présente invention concerne également des compositions pharmaceutiques comprenant ces composés. La présente invention concerne également des utilisations de ces compositions pharmaceutiques dans la prévention ou le traitement de telles maladies dans lesquelles sont impliqués les récepteurs de l'orexine.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (4)

    Publication numberPublication dateAssigneeTitle
    US-2010168134-A1July 01, 2010Breslin Michael J, Coleman Paul J, Cox Christopher D, Schreier John DPyridyl piperidine orexin receptor antagonists
    US-2011201632-A1August 18, 2011Breslin Michael J, Coleman Paul J, Cox Christopher D, Raheem Izzat T, Roecker Anthony J, Schreier John D2,5-Disubstituted Piperidine Orexin Rceptor Antagonists
    US-2012149723-A1June 14, 2012Romano Di Fabio5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder
    US-2012232052-A1September 13, 2012Tatsuya Yamagishi, Yoshimasa Arano, Mikio Morita, Tadashi InoueAryl carboxamide derivatives as ttx-s blockers

NO-Patent Citations (1)

    Title
    See also references of EP 2964226A4

Cited By (20)

    Publication numberPublication dateAssigneeTitle
    US-2015322041-A1November 12, 2015Merck Sharp & Dohme Corp.2-pyridyloxy-4-nitrile-4-substituted orexin receptor antagonists
    US-2016068510-A1March 10, 2016Merck Sharp & Dohme Corp.Hydroxy-substituted orexin receptor antagonists
    US-9546152-B2January 17, 2017Merck Sharp & Dohme Corp.2-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonists
    US-9556145-B2January 31, 2017Merck Sharp & Dohme Corp.2-pyridyloxy-4-ester orexin receptor antagonists
    US-9556190-B2January 31, 2017Merck Sharp & Dohme Corp.Piperidinyloxy lactone orexin receptor antagonists
    US-9586934-B2March 07, 2017Merck Sharp & Dohme Corp.2-pyridyloxy-4-methyl orexin receptor antagonists
    US-9617246-B2April 11, 2017Merck Sharp & Dohme Corp.Thioether-piperidinyl orexin receptor antagonists
    US-9624197-B2April 18, 2017Merck Sharp & Dohme Corp.2-pyridylamino-4-nitrile-piperidinyl orexin receptor antagonists
    US-9643955-B2May 09, 2017Merck Sharp & Dohme Corp.2-pyridyloxy-3-nitrile-4-substituted orexin receptor antagonists
    US-9676751-B2June 13, 2017Merck Sharp & Dohme Corp.2-amino-3-ester-pyridl orexin receptor antagonists
    US-9695163-B2July 04, 2017Merck Sharp & Dohme CorpThiazole orexin receptor antagonists
    US-9725434-B2August 08, 2017Merck Sharp & Dohme Corp.Hydroxy-substituted orexin receptor antagonists
    US-9745284-B2August 29, 2017Merck Sharp & Dohme Corp.2-pyridyloxy-4-ether orexin receptor antagonists
    US-9765057-B2September 19, 2017Merck Sharp & Dohme Corp.3-ester-4 substituted orexin receptor antagonists
    US-9828368-B2November 28, 2017Merck Sharp & Dohme Corp.Oxazole orexin receptor antagonists
    WO-2015088864-A1June 18, 2015Merck Sharp & Dohme Corp.Composés 2-pyridyloxy-3-ester-4-éther antagonistes des récepteurs de l'orexine
    WO-2016069510-A1May 06, 2016Merck Sharp & Dohme Corp.Antagonistes pipéridine oxadiazoles et thiadiazones des récepteurs des orexines
    WO-2016069517-A1May 06, 2016Merck Sharp & Dohme Corp.Pipéridines isoxazoles et isothiazoles antagonistes des récepteurs de l'orexine
    WO-2016069519-A1May 06, 2016Merck Sharp & Dohme Corp.Pyrazole orexin receptor antagonists
    WO-2016089722-A1June 09, 2016Merck Sharp & Dohme Corp.Hydroxymethyl piperidine orexin receptor antagonists